169 related articles for article (PubMed ID: 25286962)
1. Insulin resistance in patients on valproic acid: relation to adiponectin.
Aly RH; Amr NH; Saad WE; Megahed AA
Acta Neurol Scand; 2015 Mar; 131(3):169-75. PubMed ID: 25286962
[TBL] [Abstract][Full Text] [Related]
2. Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: A prospective study.
Sidhu HS; Srinivas R; Sadhotra A
Seizure; 2017 May; 48():15-21. PubMed ID: 28365440
[TBL] [Abstract][Full Text] [Related]
3. Vaspin and its correlation with insulin sensitivity indices in obese children.
Suleymanoglu S; Tascilar E; Pirgon O; Tapan S; Meral C; Abaci A
Diabetes Res Clin Pract; 2009 Jun; 84(3):325-8. PubMed ID: 19356820
[TBL] [Abstract][Full Text] [Related]
4. New adipocytokines (vaspin, apelin, visfatin, adiponectin) levels in children treated with valproic acid.
Meral C; Cekmez F; Vurucu S; Tascılar E; Pirgon O; Canpolat FE; Ipcioglu OM; Aydemir G; Aydınoz S
Eur Cytokine Netw; 2011 Jun; 22(2):118-22. PubMed ID: 21669562
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and insulin resistance in childhood obesity.
Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
[TBL] [Abstract][Full Text] [Related]
6. Increased oxidative stress in epileptic children treated with valproic acid.
Verrotti A; Scardapane A; Franzoni E; Manco R; Chiarelli F
Epilepsy Res; 2008 Feb; 78(2-3):171-7. PubMed ID: 18164182
[TBL] [Abstract][Full Text] [Related]
7. Fasting serum insulin and lipid levels in men with epilepsy.
Pylvänen V; Knip M; Pakarinen AJ; Turkka J; Kotila M; Rättyä J; Myllylä VV; Isojärvi JI
Neurology; 2003 Feb; 60(4):571-4. PubMed ID: 12601094
[TBL] [Abstract][Full Text] [Related]
8. Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid.
Nisha Y; Bobby Z; Wadwekar V
Seizure; 2018 Aug; 60():57-60. PubMed ID: 29906708
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.
Luef G; Rauchenzauner M; Waldmann M; Sturm W; Sandhofer A; Seppi K; Trinka E; Unterberger I; Ebenbichler CF; Joannidis M; Walser G; Bauer G; Hoppichler F; Lechleitner M
Epilepsy Res; 2009 Sep; 86(1):42-7. PubMed ID: 19464851
[TBL] [Abstract][Full Text] [Related]
10. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
Mania M; Javashvili L; Kasradze S; Okujava N
Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin and visfatin concentrations in children treated with valproic acid.
Rauchenzauner M; Haberlandt E; Scholl-Bürgi S; Ernst B; Hoppichler F; Karall D; Ebenbichler CF; Rostasy K; Luef G
Epilepsia; 2008 Feb; 49(2):353-7. PubMed ID: 18070089
[TBL] [Abstract][Full Text] [Related]
12. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
13. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
14. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
15. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents.
Keskin M; Kurtoglu S; Kendirci M; Atabek ME; Yazici C
Pediatrics; 2005 Apr; 115(4):e500-3. PubMed ID: 15741351
[TBL] [Abstract][Full Text] [Related]
16. Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children.
Atabek ME; Pirgon O
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):187-95. PubMed ID: 17396435
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and resistin concentrations after glucose load in adolescents with polycystic ovary syndrome.
Güven A; Ozgen T; Aliyazicioğlu Y
Gynecol Endocrinol; 2010 Jan; 26(1):30-8. PubMed ID: 19639497
[TBL] [Abstract][Full Text] [Related]
18. A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
Matsuhisa M; Yamasaki Y; Emoto M; Shimabukuro M; Ueda S; Funahashi T; Matsuzawa Y
Diabetes Res Clin Pract; 2007 Jul; 77(1):151-4. PubMed ID: 17081646
[TBL] [Abstract][Full Text] [Related]
19. Plasma leptin, neuropeptide Y, ghrelin, and adiponectin levels and carotid artery intima media thickness in epileptic children treated with valproate.
Tokgoz H; Aydin K; Oran B; Kiyici A
Childs Nerv Syst; 2012 Jul; 28(7):1049-53. PubMed ID: 22645062
[TBL] [Abstract][Full Text] [Related]
20. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
Luef G; Abraham I; Hoppichler F; Trinka E; Unterberger I; Bauer G; Lechleitner M
Metabolism; 2002 Oct; 51(10):1274-8. PubMed ID: 12370846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
